These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 3629749)

  • 1. Effects of castration compared with total androgen blockade on tissue dihydrotestosterone (DHT) concentration in benign prostatic hyperplasia (BPH).
    Geller J; Albert J
    Urol Res; 1987; 15(3):151-3. PubMed ID: 3629749
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of finasteride, a 5 alpha-reductase inhibitor on prostate tissue androgens and prostate-specific antigen.
    Geller J
    J Clin Endocrinol Metab; 1990 Dec; 71(6):1552-5. PubMed ID: 1699965
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of antiandrogen and/or antiestrogen blockade on human prostate epithelial and stromal cell protein synthesis.
    Geller J; Liu J; Albert J; Fay W; Berry CC
    J Steroid Biochem; 1986 Nov; 25(5B):759-63. PubMed ID: 2433506
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DHT in prostate cancer tissue--a guide to management and therapy.
    Geller J; Albert JD
    Prostate; 1985; 6(1):19-25. PubMed ID: 3969370
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship between human prostatic epithelial cell protein synthesis and tissue dihydrotestosterone level.
    Geller J; Liu J; Albert J; Fay W; Berry CC; Weis P
    Clin Endocrinol (Oxf); 1987 Feb; 26(2):155-61. PubMed ID: 3665114
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo and in vitro effects of androgen on fibroblast growth factor-2 concentrations in the human prostate.
    Geller J; Sionit LR; Baird A; Kohls M; Connors KM; Hoffman RM
    Prostate; 1994 Oct; 25(4):206-9. PubMed ID: 7521961
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Advantages of total androgen blockade in the treatment of advanced prostate cancer.
    Geller J; Albert J; Vik A
    Semin Oncol; 1988 Apr; 15(2 Suppl 1):53-61. PubMed ID: 3285484
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute effects of testicular and adrenal cortical blockade on protein synthesis and dihydrotestosterone content of human prostate tissue.
    Liu J; Geller J; Albert J; Kirshner M
    J Clin Endocrinol Metab; 1985 Jul; 61(1):129-33. PubMed ID: 2581988
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relative effectiveness of alternative androgen withdrawal therapies in initiating regression of rat prostate.
    Rennie PS; Bruchovsky N; Goldenberg SL; Lawson D; Fletcher T; Foekens JA
    J Urol; 1988 Jun; 139(6):1337-42. PubMed ID: 2967378
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rationale for blockade of adrenal as well as testicular androgens in the treatment of advanced prostate cancer.
    Geller J
    Semin Oncol; 1985 Mar; 12(1 Suppl 1):28-35. PubMed ID: 3883502
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Basis for hormonal management of advanced prostate cancer.
    Geller J
    Cancer; 1993 Feb; 71(3 Suppl):1039-45. PubMed ID: 7679038
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of megestrol acetate (Megace) on steroid metabolism and steroid-protein binding in the human prostate.
    Geller J; Albert J; Geller S; Lopez D; Cantor T; Yen S
    J Clin Endocrinol Metab; 1976 Nov; 43(5):1000-8. PubMed ID: 62759
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of androgen blockade with ketoconazole and megestrol acetate on human prostatic protein patterns.
    Liu J; Albert J; Geller J
    Prostate; 1986; 9(2):199-205. PubMed ID: 2428023
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanism of action and pure antiandrogenic properties of flutamide.
    Labrie F
    Cancer; 1993 Dec; 72(12 Suppl):3816-27. PubMed ID: 8252497
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of steroids on oxytocin secretion by the human prostate in vitro.
    Assinder SJ; Nicholson HD
    Int J Androl; 2004 Feb; 27(1):12-8. PubMed ID: 14718041
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adrenal androgen blockade in relapsed prostate cancer.
    Geller J; Albert JD
    Eur J Cancer Clin Oncol; 1985 Oct; 21(10):1127-31. PubMed ID: 2934257
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Castration-like effects on the human prostate of a 5 alpha-reductase inhibitor, finasteride.
    Geller J; Sionit L
    J Cell Biochem Suppl; 1992; 16H():109-12. PubMed ID: 1283893
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of cyproterone acetate in comparison to flutamide and megestrol acetate on the ventral prostate, seminal vesicle, and adrenal glands of adult male rats.
    el Etreby MF; Habenicht UF; Louton T; Nishino Y; Schröder HG
    Prostate; 1987; 11(4):361-75. PubMed ID: 2960960
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic options in treatment of advanced carcinoma of the prostate.
    Venner PM
    Semin Oncol; 1990 Dec; 17(6 Suppl 9):73-7. PubMed ID: 2259929
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Megestrol acetate plus low-dose estrogen in the management of advanced prostatic carcinoma.
    Geller J
    Urol Clin North Am; 1991 Feb; 18(1):83-91. PubMed ID: 1825145
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.